Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties.
Chem Sci
; 12(38): 12600-12609, 2021 Oct 06.
Article
in En
| MEDLINE
| ID: mdl-34703545
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Chem Sci
Year:
2021
Type:
Article